Advertisement

Advertisement

TARS Stock Latest News

Tarsus Pharmaceuticals price target raised to $100 from $97 at Oppenheimer

The FlyTarsus Pharmaceuticals price target raised to $100 from $97 at Oppenheimer

Tarsus Pharmaceuticals: Buy Rating Backed by Xdemvy Outperformance and Alkeus Acquisition-Driven Pipeline Expansion

PremiumRatings

Tarsus Pharmaceuticals: Buy Rating Backed by Xdemvy Outperformance and Alkeus Acquisition-Driven Pipeline Expansion

11d ago

Tarsus Pharmaceuticals price target raised to $100 from $98 at Mizuho

PremiumThe Fly

Tarsus Pharmaceuticals price target raised to $100 from $98 at Mizuho

13d ago

Analyst Reiterates Buy on Tarsus, Citing Strong XDEMVY Momentum, Ophthalmology Pipeline Expansion, and Unchanged $88 Price Target

PremiumRatings

Analyst Reiterates Buy on Tarsus, Citing Strong XDEMVY Momentum, Ophthalmology Pipeline Expansion, and Unchanged $88 Price Target

16d ago

Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet

PremiumCompany Announcements

Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet

17d ago

Tarsus to acquire Alkeus Pharmaceuticals for $450M upfront, up to $800M total

PremiumThe FlyTarsus to acquire Alkeus Pharmaceuticals for $450M upfront, up to $800M total

17d ago

Tarsus Pharmaceuticals reports Q2 EPS (43c), consensus (20c)

The Fly

Tarsus Pharmaceuticals reports Q2 EPS (43c), consensus (20c)

17d ago

Tarsus Pharmaceuticals announces $125M private placement

The Fly

Tarsus Pharmaceuticals announces $125M private placement

17d ago

Tarsus Pharmaceuticals Acquires Alkeus to Expand Retina Pipeline

PremiumCompany Announcements

Tarsus Pharmaceuticals Acquires Alkeus to Expand Retina Pipeline

17d ago

Tarsus Pharmaceuticals Raises $125M in PIPE Financing

PremiumCompany Announcements

Tarsus Pharmaceuticals Raises $125M in PIPE Financing

17d ago

Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho

PremiumThe Fly

Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho

20d ago

Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho

PremiumThe Fly

Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho

23d ago

Tarsus Pharmaceuticals price target lowered to $89 from $90 at Guggenheim

PremiumThe FlyTarsus Pharmaceuticals price target lowered to $89 from $90 at Guggenheim

1M ago

RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed

The Fly

RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed

1M ago

Tarsus Pharmaceuticals Announces Chief Commercial Officer Transition

Company Announcements

Tarsus Pharmaceuticals Announces Chief Commercial Officer Transition

1M ago

Tarsus Pharmaceuticals chief commercial officer Aziz Mottiwala to depart

PremiumThe Fly

Tarsus Pharmaceuticals chief commercial officer Aziz Mottiwala to depart

1M ago

Tarsus Pharmaceuticals: Buy Rating Backed by Capital-Efficient IRX-101 Acquisition and High-Margin Retina Market Opportunity

PremiumRatings

Tarsus Pharmaceuticals: Buy Rating Backed by Capital-Efficient IRX-101 Acquisition and High-Margin Retina Market Opportunity

2M ago

Tarsus Pharmaceuticals Acquires iRenix to Expand Retinal Care

PremiumCompany Announcements

Tarsus Pharmaceuticals Acquires iRenix to Expand Retinal Care

2M ago

Tarsus Pharmaceuticals acquires iRenix Medical

PremiumThe Fly

Tarsus Pharmaceuticals acquires iRenix Medical

2M ago

Culper Research announces Tarsus Pharmaceuticals short position

PremiumThe FlyCulper Research announces Tarsus Pharmaceuticals short position

2M ago

Tarsus drops 10% to $57.08 after Culper announces short position

The Fly

Tarsus drops 10% to $57.08 after Culper announces short position

2M ago

Tarsus Pharmaceuticals Stockholders Approve Governance and Oversight

Company Announcements

Tarsus Pharmaceuticals Stockholders Approve Governance and Oversight

2M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >